Abstract e purpose of the study is to give an overview of end-stage renal disease (ESRD) and renal replacement therapy (RRT) in the Republic of Macedonia in a period of  years (-). Data are collected by questionnaires for individual patients that are distributed to  haemodialysis centres in the country. Incidence, prevalence, mean and median age, primary renal disease, established therapy, number of renal transplants per year and mortality are assessed and elaborated. ere is an increase of incident patients on RRT over the years, from , in  to , per million population in , on day , adjusted for age and gender. Mean age of incident patients is also increasing, from ,±, at day  in , to ,±, in . Hypertension and diabetes are increasing and have become the leading cause of renal failure in incident patients at day , unadjusted, in  (, and , respectively). Prevalent counts on RRT are also increasing, from , per million population in , adjusted for age and gender, to , in . Glomerulonephritis and unknown cause of renal failure are the leading cause of ESRD in prevalent patients. Haemodialysis is the predominant RRT modality in Macedonia either for incident, or prevalent patients, and is around . e crude death rate on dialysis is relatively low, , in . Incidence and prevalence on RRT are continuously increasing, and hypertension and diabetes are becoming the leading cause of ESRD. Kidney transplantation is underrepresented and eff orts should be undertaken for its increase.
Introduction
The incidence and prevalence of End-stage-renal disease (ESRD) are continuously increasing in the United States, Canada, Australia and Europe, but recently, as a result of changes in life style, they also increase in many countries in transition. ESRD is of substantial public health importance, not only for its high mortality rate and impaired quality of life, but also for its high cost of Renal Replacement Therapy (RRT) () . The epidemiology data of patients on RRT are of great interest to health care planners and providers to forecast equipment, facility, and other resources. These data are collected by renal registries, but the extent and accuracy vary widely. There are national, regional and international renal registries. In  the International Federation of Renal Registries (IFFR) was founded for international comparison and improvement and standardization of different renal databases () .
e Macedonian Renal Registry was established in the nineties, but collecting and elaborating data was sporadically () . It started collecting data in an organized and systematic manner since  and is contributing data to the ERA-EDTA (European Renal AssociationEuropean Dialysis and Transplant Association) Renal Registry on an aggregated basis (B-section). ere are  public in-hospital dialysis centres in the Republic of Macedonia distributed evenly throughout the country. Since , responsible physicians in each dialysis centre are extending collected data for individual patients to the key-person of the national registry, and after elaborating all the collected data, the aggregated data are extended to the European Renal Registry. The purpose of this study is to give an overview of some epidemiologic data of ESRD in the Republic of Macedonia, as well as the renal replacement therapy in a period of  years (-).
Materials and Methods
According to the population census in , the general population in the Republic of Macedonia is ,, inhabitants (,, men and ,, women) . is number is used for adjustment of incident and prevalent counts of ESRD patients for age and gender to the European population of  (adjustment for the registry data of -) and to the general population of EU of the year  (adjustment for the registry data of -). e percent coverage of the general population by the renal registry is , and all the  haemodialysis centres are extending complete data for individual patients. Data on start of RRT, age, gender, primary renal disease, vascular access, type of established therapy, number or renal transplants and mortality are collected for individual patients in all the dialysis centres in the country, and extended to the national registry. e summarized data are elaborated, and incident counts on day  and , unadjusted and adjusted for age and gender, as well as prevalent counts on st December, unadjusted and adjusted for age and gender are established. Mean and median age of incident and prevalent patients, primary renal disease, established therapy m-male f-female in percentage and per million population are also established, and number of renal transplants per year. The crude death rate for a certain year is calculated by dividing the number of patients who died that year with the average number of prevalent RRT patients at the end of that year and the previous year.
Results
Incident counts on RRT per million population at day  and , unadjusted for age and gender, as well as adjusted numbers and the mean age of patients at day  and  are presented in Table  . The data show a continuous gradual increase in incident counts on RRT over the years. Incident patients are relatively young, females are older than males, but the mean age is also increasing over the years.
The primary renal disease of incident patients in percentage, at day  and , unadjusted for age and gender, and the percentage of established therapy are presented in Table  . The leading cause of ESRD in patients who start RRT in The Republic of Macedonia is hypertension, followed by diabetes and unknown cause. There is a decrease in glomerulonephritis and pyelonephritis as primary renal diseases for RRT over the years, which is accounted for by the increase of hypertension and diabetes. Haemodialysis is almost unique initial RRT, and peritoneal dialysis and kidney grafts are rarely used to initiate RRT for ESRD, but there is a slight change in the last years.
The prevalent counts per million population, unadjusted and adjusted for age and gender, the mean age of prevalent patients, the cause of renal failure in percentage and the established therapy in percentage are presented in Table  . The data also show a continuous and gradual increase in prevalent counts over the years. Prevalent patients are younger than incident patients, females are older than males, and the prevalent population is growing older over the years. The leading cause of renal failure in prevalent patients is glomerulonephritis and pyelonephritis, although the picture is changing over the years, and hypertension in  is the third leading cause for ESRD (after glomerulonephritis and unknown renal failure). Haemodialysis (HD) is the preferred renal treatment practice in the country; more than  of patients are treated with HD in . But, there is a slight increase in the number of patients treated by peritoneal dialysis and with transplanted kidneys over the years ( Table ) .
The number of renal transplants per year (Macedonian residents only) is shown in Table  . It is very low and shows no increase. Cadaveric transplantation is lacking in the country. e established therapy in percentages is shown in Figure . GN-glomerulonephritis, PN-pyelonephritis, PKD-polycystic kidney disease, DM-diabetes mellitus, HT-hypertension, RVD-renovascular disease, Misc-miscellaneous, Unkn-unknown renal disease The average percent increase in incident and prevalent patients on RRT per year (Table   and ) is approximately  (unadjusted counts, the period of -). (Table , Table  ).
The crude death rate for  and  is shown in Table  . e crude death rate for RRT is , in  Pmp-per million population and , in . It is the highest in haemodialysis patients, , in , and . in . (Table  )
Discussion
Over the past years, an increase in the prevalence of RRT has been observed in almost all Western European countries, which was partly explained by the decreased mortality, and mainly by the increased incidence rate of ESRD which was mainly accounted for by the increased acceptance rate of diabetics and older patients () . In most of the post-communistic countries of Central and Eastern Europe, as well as the Former Yugoslav countries, the incidence and prevalence rates of ESRD patients have increased after the fall of the communistic regime (). e data presented above show that the incidence rate of ESRD patients in Macedonia is relatively low, when compared to Western European countries. In , although it has increased substantially since , the incidence rate of RRT per million population, at day , adjusted for age and gender, was ,. Most of the Western European countries had much higher incidence rates, for example, Belgium, French speaking, had incidence rate of , per million population, but on the other hand, Finland and Iceland had much lower rates, , and , respectively. Greece, although being a Balkan country, had very high incidence rate of RRT in , , per million population, most probably due to the high number of diabetics with ESRD () . e mean age of incident and prevalent patients in Macedonia is below  years of age, thus being rather different than most of the Western European countries where the mean age is above , up to  years () . is is not surprising, when having in mind that the European population is older, and the acceptance rate for older ESRD patients and diabetics is much higher. Regarding cause of renal failure, the incident rates of patients with diabetes and hypertension were continuously increasing over the past years and hypertension and diabetes have become the leading cause of ESRD. The incident counts of diabetics at day , unadjusted, have increased from , in  () to , in  () . This change affects the prevalence rates, as well. The prevalence counts of diabetes and hypertension are increasing, too, but, sill, the leading cause of ESRD in prevalent patients is glomerulonephritis and unknown cause of renal failure.
Although there is an increase in the percentage of prevalent renal transplanted patients and patients on peritoneal dialysis, still, the percentage of haemodialysis as treatment modality is very high, slightly below  in , unlike most Western European countries where it ranges between  and  () . Renal transplants per year are very low and not suffi cient. Only  were performed in . Peritoneal dialysis, too, is not adequately presented in the country, the reason being the lower cost of haemodialysis compared to peritoneal dialysis due to the underpayment of medical personnel.
e crude mortality rate on RRT in Macedonia is not high. In  it was , , and the mortality rate on dialysis (haemo and peritoneal dialysis) was ,. e crude mortality annual rate in Baltic countries varies between , and  (). When compared to the data of the Slovenian Renal Registry () , the crude death rate in Macedonia is relatively low, which is mainly due to the much lower number of prevalent diabetic patients on RRT in Macedonia and younger age of patients. In , in Slovenia, the crude death rate for dialysis patients was , (, for HD and , for PD patients).
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